Seki Shoji, Hirano Norikazu, Kawaguchi Yoshiharu, Nakano Masato, Yasuda Taketoshi, Suzuki Kayo, Watanabe Kenta, Makino Hiroto, Kanamori Masahiko, Kimura Tomoatsu
Department of Orthopaedic Surgery, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Department of Orthopaedic Surgery, Toyama Rosai Hospital, Toyama, 937-0042, Japan.
Eur Spine J. 2017 Aug;26(8):2121-2127. doi: 10.1007/s00586-017-4959-0. Epub 2017 Jan 23.
Complications of adult spinal deformity surgery are problematic in osteoporotic individuals. We compared outcomes between Japanese patients treated perioperatively with teriparatide vs. low-dose bisphosphonates.
Fifty-eight osteoporotic adult Japanese female patients were enrolled and assigned to perioperative teriparatide (33 patients) and bisphosphonate (25 patients) groups in non-blinded fashion. Pre- and post-operative X-ray and computed tomography imaging were used to assess outcome, and rates were compared between the groups and according to age. Pain scores and Oswestry Disability Indices (ODI) were calculated before and 2 years after surgery.
Adjacent vertebral fractures and implant failure, fusion failure, and poor pain and ODI outcomes were significantly more common in the bisphosphonates group than the teriparatide group.
Perioperative administration of teriparatide is more effective than that of low-dose bisphosphonates in preventing complications and maintaining fusion rates in osteoporotic Japanese females with spinal deformities undergoing surgery.
成人脊柱畸形手术的并发症在骨质疏松患者中是个问题。我们比较了日本患者围手术期使用特立帕肽与低剂量双膦酸盐治疗的结果。
纳入58例骨质疏松的成年日本女性患者,非盲法将其分为围手术期使用特立帕肽组(33例患者)和双膦酸盐组(25例患者)。术前和术后的X线和计算机断层扫描成像用于评估结果,并比较两组之间以及根据年龄的发生率。计算手术前和术后2年的疼痛评分和奥斯威斯功能障碍指数(ODI)。
双膦酸盐组相邻椎体骨折、植入物失败、融合失败以及疼痛和ODI结果不佳的情况明显比特立帕肽组更常见。
对于接受手术的患有脊柱畸形的骨质疏松日本女性,围手术期给予特立帕肽在预防并发症和维持融合率方面比低剂量双膦酸盐更有效。